Low-affinity anti-HER2-CAR T cells efficiently eradicate HER2(+) and HER2(low) cancer cells with reduced toxicity on healthy tissue.
Overview & Synopsis
Open access biomedical research article published in Front Bioeng Biotechnol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Low-affinity anti-HER2-CAR T cells efficiently eradicate HER2(+) and HER2(low) cancer cells with reduced toxicity on healthy tissue. |
|---|---|
| Author / Organization | Knoedler L, Herfeld K, Scherer JN, Fan K, Shah D, Goettert S, Becker L, Lloshi I, Li S, Harrer DC, Fante MA, Wertheimer T, Schelker R, Guetter S, Tariq M, Khalid O, Scheiter A, Herr W, Schmidl C, Jesinghaus M, Tschurtschenthaler M, Poeck H, Perl M |
| Subject & Discipline | Front Bioeng Biotechnol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-118755 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |